Viewing Study NCT06360861


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-02-03 @ 1:14 PM
Study NCT ID: NCT06360861
Status: COMPLETED
Last Update Posted: 2024-04-11
First Post: 2024-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Sponsor: Tehran University of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
None Secondary-Progressive Multiple Sclerosis View
None Mesenchymal Stem Cells View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mesenchymal Stem cells View
None Multiple Sclerosis View
None Placenta derived Mesenchymal Stem Cells View
None Stem Cell therapy View
None Neuroimmunology View
None Autoimmune Disease View